Trump may issue order to cut drug prices

July 25, 2019

Industry sources say the Trump administration is looking into using an executive order to cut prescription drug prices.

Spotlight

DAVA Oncology

Optimize the recruitment and retention of patients in cancer clinical trials through the use of physician-focused approaches. DAVA has a proven track record having completed more than 45 Phase I to III trials and over the past six years with an average accrual enhancement rate of 30-40%.

OTHER VIDEOS

Filling, closing and labeling compact machines for microtubes

video | November 28, 2022

Dara Pharma designs state-of-the-art solutions for processing diagnostics reagents. We offer different equipment for this format, which is often filled in tubes, microtubes,...

Watch Now

Revolutionizing visual inspection in pharma through AI

video | November 29, 2022

That is why we have launched our AI-powered visual inspection software solution with full commitment to help pharmaceutical companies improve their product quality while reducing False Rejects and costs to a minimum....

Watch Now

User-Friendly App for pharmaceutical deliveries to your doorstep

video | November 29, 2022

With just a few clicks get the convenience of pharmaceutical deliveries to your doorstep. Experience a user-friendly app!...

Watch Now

The Future of Pharmacy Management Software

video | November 17, 2022

Welcome to the future of pharmacy management software! Axys is built from the ground up on the most modern technology. Not the most modern technology in long-term care....

Watch Now

Spotlight

DAVA Oncology

Optimize the recruitment and retention of patients in cancer clinical trials through the use of physician-focused approaches. DAVA has a proven track record having completed more than 45 Phase I to III trials and over the past six years with an average accrual enhancement rate of 30-40%.

Events